KIMS Q2 net profit rises 12% to ₹75 crore, revenue jumps 40% but margin declines

KIMS reported higher September-quarter profit and revenue, while EBITDA margin narrowed. Its board also approved a subsidiary merger and leadership reappointments.
Affected stocks
Bullish1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Krishna Inst OF MED SCI L (KIMS).
- Category: Results.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update for Krishna Inst OF MED SCI L. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.












